Terms: = Leukemia AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Prognosis
18 results:
1. The lifr Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/lifr Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract] [Full Text] [Related]
2. PCBP1 regulates lifr through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.
Streitfeld WS; Dalton AC; Howley BV; Howe PH
Cancer Biol Ther; 2023 Dec; 24(1):2271638. PubMed ID: 37927213
[TBL] [Abstract] [Full Text] [Related]
3. Genome-wide screening for differentially methylated long noncoding RNAs identifies lifr-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
[TBL] [Abstract] [Full Text] [Related]
4. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
Fan Y; Li Y; Yao X; Jin J; Scott A; Liu B; Wang S; Huo L; Wang Y; Wang R; Pool Pizzi M; Ma L; Shao S; Sewastjanow-Silva M; Waters R; Chatterjee D; Liu B; Shanbhag N; Peng G; Calin GA; Mazur PK; Hanash SM; Ishizawa J; Hirata Y; Nagano O; Wang Z; Wang L; Xian W; McKeon F; Ajani JA; Song S
Gut; 2023 Apr; 72(4):624-637. PubMed ID: 36002248
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA lifr-AS1 overexpression suppressed the progression of serous ovarian carcinoma.
Liu F; Cao L; Zhang Y; Xia X; Ji Y
J Clin Lab Anal; 2022 Aug; 36(8):e25470. PubMed ID: 35778954
[TBL] [Abstract] [Full Text] [Related]
6. High long non-coding lifr-AS1 expression correlates with poor survival in gastric carcinoma.
Wang HF; Lv JQ; Li HH; Wang W; Lin FQ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5378-5384. PubMed ID: 32495872
[TBL] [Abstract] [Full Text] [Related]
7. lifr-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
Xu F; Li H; Hu C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
[TBL] [Abstract] [Full Text] [Related]
8. Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Drozd-Sokołowska J; Zaucha JM; Żółtak T; Jamroziak K; Grzybowska-Izydorczyk O; Witkowska M; Waszczuk-Gajda A; Kaźmierczak M; Szczepaniak A; Subocz E; Knopińska-Posłuszny W; Hołojda J; Kopińska A; Hus I; Rybka J; Wołowiec D; Kwiatkowski J; Hałaburda K; Smolewski P; Giebel S; Wiktor-Jędrzejczak W
Hematol Oncol; 2019 Oct; 37(4):383-391. PubMed ID: 31026087
[TBL] [Abstract] [Full Text] [Related]
9. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
Shi Y; Gao W; Lytle NK; Huang P; Yuan X; Dann AM; Ridinger-Saison M; DelGiorno KE; Antal CE; Liang G; Atkins AR; Erikson G; Sun H; Meisenhelder J; Terenziani E; Woo G; Fang L; Santisakultarm TP; Manor U; Xu R; Becerra CR; Borazanci E; Von Hoff DD; Grandgenett PM; Hollingsworth MA; Leblanc M; Umetsu SE; Collisson EA; Scadeng M; Lowy AM; Donahue TR; Reya T; Downes M; Evans RM; Wahl GM; Pawson T; Tian R; Hunter T
Nature; 2019 May; 569(7754):131-135. PubMed ID: 30996350
[TBL] [Abstract] [Full Text] [Related]
10. A mandatory role of nuclear PAK4-lifr axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
[TBL] [Abstract] [Full Text] [Related]
11. leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.
Lei C; Lv S; Wang H; Liu C; Zhai Q; Wang S; Cai G; Lu D; Sun Z; Wei Q
DNA Cell Biol; 2018 Aug; 37(8):659-669. PubMed ID: 29902078
[TBL] [Abstract] [Full Text] [Related]
12. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating lifr and KLF4.
Lv S; Ji L; Chen B; Liu S; Lei C; Liu X; Qi X; Wang Y; Lai-Han Leung E; Wang H; Zhang L; Yu X; Liu Z; Wei Q; Lu L
Oncogene; 2018 Mar; 37(10):1354-1368. PubMed ID: 29269867
[TBL] [Abstract] [Full Text] [Related]
13. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
[TBL] [Abstract] [Full Text] [Related]
14. leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo.
Ma D; Jing X; Shen B; Liu X; Cheng X; Wang B; Fu Z; Peng C; Qiu W
Oncol Rep; 2016 Aug; 36(2):827-36. PubMed ID: 27375070
[TBL] [Abstract] [Full Text] [Related]
15. High lifr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract] [Full Text] [Related]
16. lifr functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
[TBL] [Abstract] [Full Text] [Related]
17. leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.
Liu SC; Tsang NM; Chiang WC; Chang KP; Hsueh C; Liang Y; Juang JL; Chow KP; Chang YS
J Clin Invest; 2013 Dec; 123(12):5269-83. PubMed ID: 24270418
[TBL] [Abstract] [Full Text] [Related]
18. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
[TBL] [Abstract] [Full Text] [Related]
